Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: Results of a monocentric series

World Journal of Gastroenterology

Volumn 19, Issue 47, 2013, Pages 9084-9091

  Li, Dong Yu ^a   Zhang, Hai Bin ^a   Yang, Ning ^a   Quan, Yuan ^a   Yang, Guang Shun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Intrahepatic cholangiocarcinoma; Lymph node dissection; Lymph node metastases; Postoperative survival

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIVER FUNCTION; LIVER RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL; TUMOR VOLUME;

INTRAHEPATIC CHOLANGIOCARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASES; POSTOPERATIVE SURVIVAL;

ADULT; AGED; CHOLANGIOCARCINOMA; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84890894815     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i47.9084     Document Type: Article

References (45)

1. Casavilla FA, Marsh JW, Iwatsuki S, Todo S, Lee RG, Madar-iaga JR, Pinna A, Dvorchik I, Fung JJ, Starzl TE. Hepatic resection and transplantation for peripheral cholangiocarci-noma. J Am Coll Surg 1997; 185: 429-436 [PMID: 9358085]
2. Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, Takayasu K, Nakanuma Y, Makuuchi M, Matsuyama Y, Monden M, Kudo M. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res 2007; 37: 676-691 [PMID: 17617112 DOI: 10.1111/j.1872-034X.2007.00119.x]
3. Shimada M, Yamashita Y, Aishima S, Shirabe K, Tak-enaka K, Sugimachi K. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 2001; 88: 1463-1466 [PMID: 11683741 DOI: 10.1046/ j.0007-1323.2001.01879.x]
4. Yamamoto M, Takasaki K, Yoshikawa T. Lymph node metastasis in intrahepatic cholangiocarcinoma. Jpn J Clin Oncol 1999; 29: 147-150 [PMID: 10225697 DOI: 10.1093/ jjco/29.3.147]
5. Sobin LH, Wittekind C, editors. International Union Against Cancer (UICC): TNM Classification of Malignant Tumors. 5th ed. New York: John Wiley and Sons, 1997
6. Shimada H, Endo I, Togo S, Nakano A, Izumi T, Nakaga-wara G. The role of lymph node dissection in the treatment of gallbladder carcinoma. Cancer 1997; 79: 892-899 [PMID: 9041150]
7. Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yama-moto H, Hayakawa N, Nimura Y. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg 2001; 233: 385-392 [PMID: 11224627 DOI: 10.1097/00000 658-200103000-00013]
8. Ribero D, Pinna AD, Guglielmi A, Ponti A, Nuzzo G, Gi-ulini SM, Aldrighetti L, Calise F, Gerunda GE, Tomatis M, Amisano M, Berloco P, Torzilli G, Capussotti L. Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 434 Patients. Arch Surg 2012; 147: 1107-1113 [PMID: 22910846 DOI: 10.1001/archsurg.2012.1962]
9. De Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alex-andrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L, Ferrone CR, Zhu AX, Bauer TW, Walters DM, Gamblin TC, Nguyen KT, Turley R, Popescu I, Hubert C, Meyer S, Schulick RD, Choti MA, Gigot JF, Mentha G, Paw-lik TM. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 2011; 29: 3140-3145 [PMID: 21730269 DOI: 10.1200/JCO.2011.35.6519]
10. Patel T. Increasing incidence and mortality of primary in-trahepatic cholangiocarcinoma in the United States. Hepa-tology 2001; 33: 1353-1357 [PMID: 11391522 DOI: 10.1053/ jhep.2001.25087]
11. Weber SM, Jarnagin WR, Klimstra D, DeMatteo RP, Fong Y, Blumgart LH. Intrahepatic cholangiocarcinoma: resect-ability, recurrence pattern, and outcomes. J Am Coll Surg 2001; 193: 384-391 [PMID: 11584966 DOI: 10.1016/S1072-7515(01)01016-X]
12. El Rassi ZE, Partensky C, Scoazec JY, Henry L, Lombard-Bohas C, Maddern G. Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management. Eur J Surg Oncol 1999; 25: 375-380 [PMID: 10419707 DOI: 10.1053/ ejso.1999.0660]
13. Yang T, Zhang J, Lu JH, Yang LQ, Yang GS, Wu MC, Yu WF. A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort. J Cancer Res Clin Oncol 2011; 137: 739-750 [PMID: 20607551 DOI: 10.1007/s00432-010-0935-3]
14. Nathan H, Pawlik TM. Staging of intrahepatic cholangio-carcinoma. Curr Opin Gastroenterol 2010; 26: 269-273 [PMID: 20179593 DOI: 10.1097/MOG.0b013e328337c899]
15. Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Yamazaki O, Kinoshita H. Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocar-cinoma. Br J Surg 2001; 88: 969-974 [PMID: 11442529 DOI: 10.1046/j.0007-1323.2001.01784.x]
16. Okabayashi T, Yamamoto J, Kosuge T, Shimada K, Yama-saki S, Takayama T, Makuuchi M. A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 2001; 92: 2374-2383 [PMID: 11745293]
17. Inoue K, Makuuchi M, Takayama T, Torzilli G, Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Konishi M, Kinoshita T, Miyagawa S, Kawasaki S. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 2000; 127: 498-505 [PMID: 10819057 DOI: 10.1067/msy.2000.104673]
18. Kawarada Y, Yamagiwa K, Das BC. Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg 2002; 183: 679-685 [PMID: 12095601 DOI: 10.1016/S0002-9610(02)00853-X]
19. Isa T, Kusano T, Shimoji H, Takeshima Y, Muto Y, Furukawa M. Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. Am J Surg 2001; 181: 507-511 [PMID: 11513774 DOI: 10.1016/S0002-9610(01)00628-6]
20. Shirabe K, Shimada M, Harimoto N, Sugimachi K, Yamashi-ta Y, Tsujita E, Aishima S. Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery 2002; 131: S159-S164 [PMID: 11821804 DOI: 10.1067/ msy.2002.119498]
21. Suzuki S, Sakaguchi T, Yokoi Y, Okamoto K, Kurachi K, Tsuchiya Y, Okumura T, Konno H, Baba S, Nakamura S. Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarci-noma. World J Surg 2002; 26: 687-693 [PMID: 12053220 DOI: 10.1007/s00268-001-0291-1]
22. Uenishi T, Yamazaki O, Yamamoto T, Hirohashi K, Tanaka H, Tanaka S, Hai S, Kubo S. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. J Hepato-biliary Pancreat Surg 2005; 12: 479-483 [PMID: 16365823 DOI: 10.1007/s00534-005-1026-8]
23. Morimoto Y, Tanaka Y, Ito T, Nakahara M, Nakaba H, Nishida T, Fujikawa M, Ito T, Yamamoto S, Kitagawa T. Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobili-ary Pancreat Surg 2003; 10: 432-440 [PMID: 14714164 DOI: 10.1007/s00534-002-0842-3]
24. Nakagawa T, Kamiyama T, Kurauchi N, Matsushita M, Na-kanishi K, Kamachi H, Kudo T, Todo S. Number of lymph node metastases is a significant prognostic factor in intra-hepatic cholangiocarcinoma. World J Surg 2005; 29: 728-733 [PMID: 15880276 DOI: 10.1007/s00268-005-7761-9]
25. Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yo-shidome H, Miyazaki M. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002; 89: 1525-1531 [PMID: 12445060 DOI: 10.1046/j.1365-2168.2002.02268.x]
26. Saxena A, Chua TC, Sarkar A, Chu F, Morris DL. Clini-copathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahe-patic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit. J Gastrointest Surg 2010; 14: 1128-1138 [PMID: 20467830 DOI: 10.1007/ s11605-010-1203-1]
27. Ercolani G, Vetrone G, Grazi GL, Aramaki O, Cescon M, Ravaioli M, Serra C, Brandi G, Pinna AD. Intrahepatic chol-angiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. Ann Surg 2010; 252: 107-114 [PMID: 20531002 DOI: 10.1097/SLA.0b013e3181e462e6]
28. Cho SY, Park SJ, Kim SH, Han SS, Kim YK, Lee KW, Lee SA, Hong EK, Lee WJ, Woo SM. Survival analysis of intrahepatic cholangiocarcinoma after resection. Ann Surg Oncol 2010; 17: 1823-1830 [PMID: 20165987 DOI: 10.1245/s10434-010-0938-y]
29. Shirabe K, Mano Y, Taketomi A, Soejima Y, Uchiyama H, Aishima S, Kayashima H, Ninomiya M, Maehara Y. Clini-copathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocar-cinoma: relevance of the lymphatic invasion index. Ann Surg Oncol 2010; 17: 1816-1822 [PMID: 20135355 DOI: 10.1245/ s10434-010-0929-z]
30. Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Val-degamberi A, Nicoli P, Cappellani A, Malfermoni G, Iacono C. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg 2009; 33: 1247-1254 [PMID: 19294467 DOI: 10.1007/s00268-009-9970-0]
31. Tamandl D, Kaczirek K, Gruenberger B, Koelblinger C, Maresch J, Jakesz R, Gruenberger T. Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. Br J Surg 2009; 96: 919-925 [PMID: 19591163 DOI: 10.1002/ bjs.6654]
32. Shimada K, Sano T, Nara S, Esaki M, Sakamoto Y, Kosuge T, Ojima H. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangio-cellular carcinoma with negative lymph node involvement. Surgery 2009; 145: 411-416 [PMID: 19303990 DOI: 10.1016/ j.surg.2008.11.010]
33. Yedibela S, Demir R, Zhang W, Meyer T, Hohenberger W, Schönleben F. Surgical treatment of mass-forming intrahe-patic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients. Ann Surg Oncol 2009; 16: 404-412 [PMID: 19037702 DOI: 10.1245/s10434-008-0227-1]
34. Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World J Surg 2008; 32: 2675-2680 [PMID: 18843437 DOI: 10.1007/s00268-008-9778-3]
35. Uenishi T, Kubo S, Yamazaki O, Yamada T, Sasaki Y, Nagano H, Monden M. Indications for surgical treatment of intra-hepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg 2008; 15: 417-422 [PMID: 18670844 DOI: 10.1007/s00534-007-1315-5]
36. Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H. Clinical impact of the surgical margin status in hepatec-tomy for solitary mass-forming type intrahepatic cholan-giocarcinoma without lymph node metastases. J Surg Oncol 2007; 96: 160-165 [PMID: 17443744 DOI: 10.1002/jso.20792]
37. Choi SB, Kim KS, Choi JY, Park SW, Choi JS, Lee WJ, Chung JB. The prognosis and survival outcome of intrahepatic chol-angiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 2009; 16: 3048-3056 [PMID: 19626372 DOI: 10.1245/s10434-009-0631-1]
38. Asakura H, Ohtsuka M, Ito H, Kimura F, Ambiru S, Shimizu H, Togawa A, Yoshidome H, Kato A, Miyazaki M. Long-term survival after extended surgical resection of intrahepat-ic cholangiocarcinoma with extensive lymph node metastasis. Hepatogastroenterology 2005; 52: 722-724 [PMID: 15966191]
39. Uenishi T, Yamazaki O, Horii K, Yamamoto T, Kubo S. A long-term survivor of intrahepatic cholangiocarcinoma with paraaortic lymph node metastasis. J Gastroenterol 2006; 41: 391-392 [PMID: 16741622 DOI: 10.1007/s00535-006-1757-6]
40. Ercolani G, Grazi GL, Ravaioli M, Grigioni WF, Cescon M, Gardini A, Del Gaudio M, Cavallari A. The role of lymphade-nectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg 2004; 239: 202-209 [PMID: 14745328 DOI: 10.1097/01.sla.0000109154.00020.e0]
41. Miwa S, Miyagawa S, Kobayashi A, Akahane Y, Nakata T, Mihara M, Kusama K, Soeda J, Ogawa S. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 2006; 41: 893-900 [PMID: 17048054 DOI: 10.1007/s00535-006-1877-z]
42. Nakagohri T, Asano T, Kinoshita H, Kenmochi T, Urashima T, Miura F, Ochiai T. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarci-noma. World J Surg 2003; 27: 289-293 [PMID: 12607053 DOI: 10.1007/s00268-002-6696-7]
43. Gibbs JF, Weber TK, Rodriguez-Bigas MA, Driscoll DL, Pe-trelli NJ. Intraoperative determinants of unresectability for patients with colorectal hepatic metastases. Cancer 1998; 82: 1244-1249 [PMID: 9529015]
44. Grobmyer SR, Wang L, Gonen M, Fong Y, Klimstra D, D' Angelica M, DeMatteo RP, Schwartz L, Blumgart LH, Jar-nagin WR. Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg 2006; 244: 260-264 [PMID: 16858189 DOI: 10.1097/01. sla.0000217606.59625.9d]
45. Sun HC, Zhuang PY, Qin LX, Ye QH, Wang L, Ren N, Zhang JB, Qian YB, Lu L, Fan J, Tang ZY. Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphad-enectomy. J Surg Oncol 2007; 96: 37-45 [PMID: 17345597 DOI: 10.1002/jso.20772]